Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-28

Clinical Trial Update: Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3 [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating aflibercept in combination with pranoprofen eye drops or omega-3 nutraceutical support for macular edema related to choroidal neovasc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EYLEA (Aflibercept)
  • Omega-3 fatty acids supplement (Omega-3 fatty acids)
  • Pranoprofen eye drops (pranoprofen)

Snippet

Sponsor: Università degli Studi di Brescia | Conditions: Macular Edema | Phase 4 | Status: COMPLETED